Tuberk Toraks 2020;68(4):469-470
Subject Index
469
SUBJECT INDEX
A-B-C A liver cycst hydatid case with widespread embolies to vena cava inferior 346-350 A massive pulmonary thromboembolism after pulmonary endarterectomy: a case report 76-79
A new predictor to determine the exacerbation and
treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio 260-267
A rare but a serious complication: gemifloxacin induced tendinopathy 184-187 A retrospective evaluation of the pulmonary function tests and quality of life assessment surveys of emphysema patients subject to coil treatment 399-406
A very rare fatal complication:
bilateral reexpansion pulmonary edema after treatment of single side total pneumothothorax 188-191 Anti-IL-5 treatments in severe eosinophilic asthma: real life datas 148-159
A-rare-case of h-type tracheoesophageal fistula treated with slide tracheoplasty 449-452
Asthma and COVID-19: What do we know? 141-147
Behcet’s disease presenting with pulmonary
thromboembolism 337-341
Bronchiectasis in Turkey:
Under the light of national publications 48-65
Can tissue elemental analysis be used to differentiate sarcoidosis and tuberculous lymphadenitis? 126-134 Clinical impact of depression and anxiety in patients with non-cystic fibrosis
bronchiectasis 103-111 Clinical presentation of health care workers with symptoms of coronavirus disease 2019 at the İzmir tertiary education hospital, during an early phase of the pandemic 218-226
Complete resections of giant thorax masses and
experienced difficulties 278-284
Completely disappearance of opacity of pulmonary cryptococcosis with salazosulfapyridine for rheumatoid arthritis 351-352 COVID-19 and acute kidney injury 407-418
COVID-19 infections and pulmonary rehabilitation 192- 194
COVID-19 pneumonia and pneumothorax: case series 437-443
D-E-F
D-dimer levels and COVID- 19 severity: systematic review and meta-analysis 353-360
Diagnostic importance of maximum intensity projection technique in the identification of small pulmonary nodules with computed tomography 35-42
Diagnostic importance of maximum intensity projection technique in the identification of small pulmonary nodules with computed tomography 196-197
Diagnostic performance of EBUS-TBNA and its interrelation with PET-CT in patients with extra-thoracic malignancies 285-292 Diagnostic value of CD4+, CD8+ and CD103+
lymphocytes in mediastinal lymph node specimens obtained via endobronchial ultrasonography for
sarcoidosis 96-102
Does spirometric tests meet the acceptability criteria? Data from a tertiary chest hospital in Turkey 112-117
Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis 227-235
Evaluation of transcutaneous carbon dioxide and saturation monitoring during fiberoptic bronchoscopy 379-387 Fatal contralateral
pneumothorax in a patient with pneumonectomy 461-462
Tuberk Toraks 2020;68(4):469-470 Subject Index
470
H-I
High flow nasal cannula in COVID-19: a literature review 168-174
Hyponatremia prolongs hospital stay in patients with community- acquired pneumonia 198-199 Immunotherapy and
multidisciplinary approach to treatment in lung cancer 66-75 Inflammatory myofibroblastic tumor of the lung: histopathology and imaging findings 321-327 Influenza or other respiratory viruses: does it matter as the cause of acute respiratory failure in the critically-ill patients? 388-398 Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD? 252-259 Is there any effect of smoking status on severity and mortality of hospitalized patients with COVID-19 pneumonia? 371-378
L-M-N Levels of YKL-40 in pleural effusion and blood from patients with pleuritis 268-277
Lymphoepithelioma-like
carcinoma of the lung: a rare case report and review of the literature 453-457
Management of obstructive sleep apnea during COVID-19
pandemic 135-140
Maximum intensity projection technique in the identification of small pulmonary nodules 195 Mortality prediction ability of phycians in intensive care units of Turkey (MOPAP) 205-217
Nowadays COVID underestimates the other suspects 342-345
P-R-S Pathological features of
COVID-19 infection from biopsy and autopsy series 160-167 Pneumococcal infections and protection with vaccination in adult chronic lung diseases 305- 320
Polysomnographic, demographic and clinic differences between male and female obstructive sleep apnea patients 361-370
Post-COVID-19 pulmonary sequla: longterm follow up and management 419-429
Prone positioning in non-intubated patients with COVID-19 331-336 Pulmonary infections due to brucellosis in childhood 43-47 Real life results of coil treatment for bronchoscopic lung volume reduction in emphysema 17-24 Relationship between ghrelin and obestatin levels and ghrelin/
obestatin ratio in patients with asthma 9-16
Successful treatment of COVID-19 infection in a patient with
tracheostomy 444-448
T
The analysis of the top 100 most cited publications in chest diseases in Turkey (1975-2019): a bibliometric analysis 81-95 The association of
clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non- small cell lung cancer 118-125
The comparison of the survival rates of intensive and palliative care units 245-251
The cost of pulmonary thromboembolism treatment 293-304
The relationship between the heart-type fatty acid binding protein levels, carotid intima media thickness and epicardial fat thickness in patients with
obstructive sleep apnea syndrome 1-8
The rising star ‘tele-pulmonary rehabilitation’ in pandemic times the first application from Turkey 458-460
The role of mesenchymal stem cells in COVID-19 treatment 430-436
Treatment approach to apnestic breathing in a patient with vocal cord paralysis due to Arnold Chiari malformation and tracheostomy 175-183
Treatment approach to apnestic breathing in Arnold Chiari malformation: any role of non- invasive ventilation? 463-464 Tuberculosis risk in patients with rheumatologic disease treated with biologic drugs 236-244
V-W
Vitamin D status in hospitalized patients with chronic obstructive pulmonary disease 25-34
What is the role of montelukast in asthma treatment? 328-330
